These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preventing cardiovascular events with angiotensin II receptor blockers: a closer look at telmisartan and valsartan. Volpe M Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):1061-72. PubMed ID: 23030295 [TBL] [Abstract][Full Text] [Related]
3. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. White WB; Lacourciere Y; Davidai G Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889 [TBL] [Abstract][Full Text] [Related]
4. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension. White WB; Davidai G; Schumacher H J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698 [TBL] [Abstract][Full Text] [Related]
5. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property. Yamagishi S; Takeuchi M Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852 [TBL] [Abstract][Full Text] [Related]
7. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)]. Scholze J; Müller U MMW Fortschr Med; 2006 Oct; 148(42):48. PubMed ID: 17621800 [No Abstract] [Full Text] [Related]
8. Angioedema due to valsartan. Martínez Alonso JC; Domínguez Ortega FJ; Méndez Alcalde J; Fuentes Gonzalo MJ Allergy; 2003 Apr; 58(4):367. PubMed ID: 12708991 [No Abstract] [Full Text] [Related]
9. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial. White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920 [TBL] [Abstract][Full Text] [Related]
10. Linear lichenoid drug eruption induced by valsartan. Gencoglan G; Ceylan C; Kazandi AC Clin Exp Dermatol; 2009 Oct; 34(7):e334-5. PubMed ID: 19456765 [No Abstract] [Full Text] [Related]
11. Telmisartan or valsartan alone or in combination with hydrochlorothiazide: a review. Lacourcière Y Clin Exp Hypertens; 2013; 35(1):50-60. PubMed ID: 22866964 [TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring. Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956 [TBL] [Abstract][Full Text] [Related]
13. Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes. Luzio SD; Dunseath G; Owens DR Horm Metab Res; 2002 May; 34(5):271-4. PubMed ID: 12063642 [TBL] [Abstract][Full Text] [Related]
15. [Acute hepatitis induced by valsartan]. Reñé JM; Buenestado J; Sesé E; Miñana JM Med Clin (Barc); 2001 Nov; 117(16):637-8. PubMed ID: 11714476 [No Abstract] [Full Text] [Related]
16. [Angioedema and urticarial reaction induced by valsartan]. de la Serna Higuera C Med Clin (Barc); 2000 Apr; 114(15):599. PubMed ID: 10846683 [No Abstract] [Full Text] [Related]
17. Nightmares induced by valsartan. Kastalli S; El AS; Loueslati MH; Daghfous R; Belkahia C Therapie; 2006; 61(1):81-2. PubMed ID: 16792161 [No Abstract] [Full Text] [Related]
18. Effects of telmisartan and valsartan on insulin sensitivity in obese diabetic mice. Ushijima K; Takuma M; Ando H; Ishikawa-Kobayashi E; Nozawa M; Maekawa T; Shiga T; Fujimura A Eur J Pharmacol; 2013 Jan; 698(1-3):505-10. PubMed ID: 23195328 [TBL] [Abstract][Full Text] [Related]
19. The occurrence rate of cerebrovascular and cardiac events in patients receiving antihypertensive therapy from the post-marketing surveillance data for valsartan in Japan (J-VALID). Yamazaki T; Kohro T; Chujo M; Ishigaki M; Hashimoto T Hypertens Res; 2013 Feb; 36(2):140-50. PubMed ID: 23096231 [TBL] [Abstract][Full Text] [Related]
20. Second study on valsartan is threatened with retraction over alleged data manipulation. Mahony C BMJ; 2013 Aug; 347():f4920. PubMed ID: 23918698 [No Abstract] [Full Text] [Related] [Next] [New Search]